Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Condition(s):Glioblastoma MultiformeLast Updated:February 23, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Glioblastoma MultiformeLast Updated:February 23, 2024Recruiting
Condition(s):Long COVID; Post-COVID19 Condition; Post-Acute COVID19 SyndromeLast Updated:March 7, 2024Recruiting
Condition(s):Post-COVID-19 SyndromeLast Updated:December 28, 2022Not yet recruiting
Condition(s):COVID-19Last Updated:February 21, 2023Recruiting
Condition(s):Disorder of ConsciousnessLast Updated:February 1, 2024Recruiting
Condition(s):Multiple Sclerosis; FatigueLast Updated:December 11, 2023Recruiting
Condition(s):Stroke, Ischemic; Stroke HemorrhagicLast Updated:February 21, 2024Recruiting
Condition(s):Traumatic Brain InjuryLast Updated:February 23, 2024Not yet recruiting
Condition(s):Traumatic Brain InjuryLast Updated:September 28, 2023Recruiting
Condition(s):Long COVID; Post-Acute COVID-19 SyndromeLast Updated:January 31, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.